The FDA has issued a warning for Viberzi that patients who do not have a gallbladder have an increased risk of developing serious pancreatitis. The FDA has issued a warning for Viberzi, which is used ...
The FDA has issued a warning that the drug product Viberzi (generic name eluxadoline), which is used to treat irritable bowel syndrome with diarrhea, should not be used in patients who do not have a ...
FDA Warns of Increased Risk of Serious Pancreatitis with Allergan’s Viberzi Following the death of two patients without a gallbladder on Allergan’s irritable bowel drug Viberzi (eluxadoline), the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results